So first it was enteric infections and bone fractures, now, the latest evidence suggests PPIs increase the risk of developing type 2 diabetes.

Following analysis of data from three large prospective cohorts, Chinese researchers have determined that taking PPIs regularly (and that’s only two or more times a week) confers a 24% higher risk of developing type 2 diabetes than if the acid-suppressing medication isn’t being taken.